Sun Pharmaceutical Industries Ltd share price logo

Sun Pharma Share Price

NSE: SUNPHARMA

BSE: 524715

Large Cap

Healthcare Sector

₹1757.10

+19.70

(+1.13%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sun Pharma Stock Performance

as on November 14, 2025 at 4:01 pm IST

  • Day's Low

    Day's High

    ₹1,734.7
    ₹1,760.1
    downward going graph

    1.27%

    Downside

    0.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹1,548
    ₹1,910
    downward going graph

    11.90%

    Downside

    8.70%

    Upside

    downward going graph

Sun Pharma share price movements today

Previous Close
₹1,737.40
Open
₹1,737.40
Volume
16.67L
Upper Circuit
₹1,911.10
Lower Circuit
₹1,563.70
Day's Low - High
₹1,734.7 - ₹1,760.1
52 Week Low - High
₹1,548 - ₹1,910

Sun Pharma Historical Returns

1 Month Return
+ 6.16 %
3 Month Return
+ 7.62 %
1 Year Return
+ 0.53 %
3 Year Return
+ 72.93 %
5 Year Return
+ 238.95 %

Sun Pharma Fundamentals

as on November 14, 2025 at 4:01 pm IST

Market Cap

₹4,21,587.15 Cr

Return on Equity (ROE)

17.83

PE Ratio (TTM)

40.3

Return on capital employed (ROCE)

16.29

Industry PE ratio

42.22

Beta (LTM)

0.67

P/B Ratio

17.11

Dividend Yield

0.92

PEG Ratio

-16.12

Quarterly Earnings Growth YOY

3.51

EPS (TTM)

45.76

Sector

Pharmaceuticals

Book Value

301

Technical Analysis

Bullish

View Technical Analysis

Sun Pharma Stock Valuation

as on November 14, 2025 at 4:01 pm IST

Sun Pharma in the last 5 years

  • Overview

  • Trends

Lowest (19.47x)

March 23, 2020

Today (40.30x)

November 14, 2025

Industry (42.22x)

November 14, 2025

Highest (184.63x)

August 28, 2020

LowHigh

Today’s Price to Earnings Ratio: 40.30x

Sun Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharmaceutical Industries Ltd image
Sun Pharmaceutical Industries Ltd
BUY4,21,587.1547.79%0.5210,98052,578
Divis Laboratories Ltd image
Divis Laboratories Ltd
HOLD1,72,859.8718%0.502,1919,360
Torrent Pharmaceuticals Ltd image
Torrent Pharmaceuticals Ltd
BUY1,29,679.7037.7%0.661,91111,516
Biocon Ltd image
Biocon Ltd
BUY54,969.26-0.79%0.781,42915,261
Gland Pharma Ltd image
Gland Pharma Ltd
HOLD30,150.420.11%0.536985,616
See all

Analyst Recommendation on Sun Pharma Stock

Based on 37 analysts

BUY

86.49%

Buy

2.70%

Hold

10.81%

Sell

Based on 37 analysts, 86.49% of analysts recommend a 'BUY' rating for Sun Pharma. Average target price of ₹1940.95

Source: S&P Global Market Intelligence

Sun Pharma Share Price Target

Get share price movements and forecasts by analysts on Sun Pharma.

What analysts predicted

10.46%UPSIDE

Target Price

₹1940.95

Current Price

₹1757.1

Analyzed by

37 Analysts

High

₹2450

Target

₹1940.95

Low

₹1570

Sun Pharma target price ₹1940.95, a slight upside of 10.46% compared to current price of ₹1757.1. According to 37 analysts rating.

Source: S&P Global Market Intelligence

Sun Pharma Stock’s Investor Sentiment and Interest

Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has dropped by -28.37% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-28.37% versus previous 30 day period

Search interest for Sun Pharmaceutical Industries Ltd Stock has decreased by -5% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-5% versus previous 30 day period

Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Sales
11,100.14
10,725.57
11,785.15
12,003.11
12,156.86
11,813.33
12,524.51
13,264.22
13,436.94
12,815.58
13,786.07
14,405.22
Other Income
173.88
373.28
204.44
293.61
250.2
605.94
532.55
354
465.62
612.87
464.46
469.92
Total Income
11,414.85
11,303.95
12,145.28
12,486.02
12,630.9
12,588.84
13,185.3
13,645.39
14,141.08
13,571.71
14,315.86
14,948.23
Expenses
8,237.25
8,299.99
8,931.94
9,013.03
8,973.68
9,049.39
9,045.13
9,352.43
9,982.61
9,604.43
10,367.74
9,951.26
Operating Profit
2,862.89
2,425.58
2,853.21
2,990.08
3,183.18
2,763.94
3,479.38
3,911.79
3,454.33
3,211.15
3,418.33
4,453.96
Operating Profit Margin %
25.79%
22.61%
24.21%
24.91%
26.18%
23.4%
27.78%
29.49%
25.71%
25.06%
24.8%
30.92%
Profit Before Interest, Tax and Depreciation
3,177.6
3,003.96
3,213.34
3,472.99
3,657.22
3,539.45
4,140.17
4,292.96
4,158.47
3,967.28
3,948.12
4,996.97
Interest
46.18
92.74
80.88
49.29
34.73
73.57
61.54
69.17
51.51
49.14
74.8
99.86
Depreciation
659.95
671.53
651.32
632.82
622.14
650.36
655.13
625.91
630.56
663.79
700.55
729.5
Profit Before Tax
2,471.47
2,239.69
2,481.14
2,790.88
3,000.35
2,815.52
3,423.5
3,597.88
3,476.4
3,254.35
3,172.77
4,167.61
Tax Paid
283.43
222.91
468.1
390.1
432.32
148.93
552.25
567.21
558.86
1,093.71
870.15
1,030.52
Profit After Tax
2,188.04
2,016.78
2,013.04
2,400.78
2,568.03
2,666.59
2,871.25
3,030.67
2,917.54
2,160.64
2,302.62
3,137.09
Total Net profit including share of profit / Loss from associate company
2,180.75
1,982.9
2,005.65
2,385.1
2,560.54
2,658.74
2,860.51
3,037.33
2,912.98
2,153.93
2,292.87
3,124.95
EPS
9
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
Actual EPS
9
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
Adjusted EPS
9
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13
Diluted EPS
9
8.3
8.4
9.9
10.5
11.1
11.8
12.7
12.1
9
9.5
13

Sun Pharmaceutical Industries Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
30,264.23
26,065.94
28,686.28
32,325.17
33,233.08
38,426.42
43,278.87
47,758.45
52,041.25
Other Income
623.15
838.76
1,025.49
635.98
835.52
921.51
634.52
1,354.19
1,965.04
Total Income
32,201.59
27,328.22
30,091.4
33,473.48
34,333.66
39,576
44,520.2
49,851.04
54,543.48
Expenses
21,489.17
21,831.83
23,972.7
26,108.38
29,312.91
32,823.59
32,410.34
35,968.04
37,984.6
Operating Profit
8,775.06
4,234.11
4,713.58
6,216.79
3,920.17
5,602.83
10,868.53
11,790.41
14,056.65
Operating Profit Margin %
28.99%
16.24%
16.43%
19.23%
11.8%
14.58%
25.11%
24.69%
27.01%
Profit Before Interest, Tax and Depreciation
10,712.42
5,496.39
6,118.7
7,365.1
5,020.75
6,752.41
12,109.86
13,883
16,558.88
Interest
399.8
517.57
555.25
302.73
141.43
127.35
172
238.47
231.36
Depreciation
1,264.75
1,499.84
1,753.25
2,052.78
2,079.95
2,143.74
2,529.43
2,556.64
2,575.39
Profit Before Tax
9,047.87
3,478.98
3,810.2
5,009.59
2,799.37
4,481.32
9,408.43
11,087.89
13,752.13
Tax Paid
1,211.57
911.04
600.88
822.8
514.69
1,075.5
847.59
1,439.45
2,772.03
Profit After Tax
7,836.3
2,567.94
3,209.32
4,186.79
2,284.68
3,405.82
8,560.84
9,648.44
10,980.1
Total Net profit including share of profit / Loss from associate company
7,846.23
2,542.5
3,207.86
4,171.96
2,272.35
3,389.28
8,512.94
9,610.03
10,964.75
EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Actual EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Adjusted EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6
Diluted EPS
29
8.73
11.11
15.69
12.1
13.6
35.3
39.9
45.6

Sun Pharmaceutical Industries Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
6,685.86
7,082.21
3,907.15
2,196.45
6,554.77
6,170.37
8,984.54
4,959.33
12,134.98
14,072.09
Cash Flow from Investing Activities
-3,949.13
-4,186.15
-3,103.8
-310.08
-2,225.32
406.53
-5,555.86
-7,219.92
-762.9
-5,183.15
Cash Flow from Financing Activities
-1,888.53
-2,285.39
-1,539.26
-2,730.52
-5,715.14
-5,980.48
-5,193.46
2,376.07
-6,710.16
-7,905.82
Net Cash Flow
848.2
610.67
-735.91
-844.15
-1,385.69
596.42
-1,764.78
115.48
4,661.92
983.12

Sun Pharma Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Promoters
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
54.48%
DII
19.14%
19.24%
19.75%
19.67%
17.97%
18.83%
19.28%
18.61%
18.55%
18.7%
19.5%
20.23%
FII
0%
0%
0%
16.79%
0%
17.72%
17.23%
18.02%
18.05%
17.96%
17.26%
16.55%
Public
9.51%
9.39%
9.29%
9.06%
8.92%
8.97%
9.01%
8.89%
8.92%
8.87%
8.77%
8.73%
Total Outstanding Shares
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
2,39,93,34,970
Total Shareholders
6,32,337
6,25,252
6,24,561
6,16,588
6,12,626
6,31,392
6,73,217
6,57,317
6,89,623
7,04,983
7,23,770
7,43,877

Mutual Funds that own Sun Pharma Stock

Check out the Mutual Funds with significant holdings in Sun Pharma.

Sun Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharma.

  • Sun Pharmaceutical Industries Ltd Earnings Results

    Sun Pharmaceutical Industries Ltd’s net profit jumped 2.56% since last year same period to ₹3,117.95Cr in the Q2 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 36.83% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Sun Pharmaceutical Industries Ltd Dividends May,2025

    In the quarter ending March 2025, Sun Pharmaceutical Industries Ltd has declared dividend of ₹5.50 per share on 22 May 2025 - translating a dividend yield of 1.21%.

    Read More about Dividends

Indices Featuring Sun Pharma Stock

Check stock indices that include Sun Pharma.

S&P BSE Low Volatility

₹1,880.16

0.19 (▲3.48%)

Nifty Healthcare

₹14,871.85

0.42 (▲62.5%)

Nifty100 Low Volatility 30

₹20,898.05

0 (▲0.7%)

NIFTY PHARMA

₹22,821.05

0.59 (▲134.25%)

Nifty 200

₹14,472.60

0.08 (▲12.05%)

S&P BSE SENSEX 50

₹27,045.33

0.05 (▲12.73%)

Nifty 500

₹23,836.35

0.09 (▲20.35%)

S&P BSE Dividend Stability

₹1,038.24

-0.26 (▲-2.75%)

NIFTY 50

₹25,910.05

0.12 (▲30.9%)

S&P BSE Largecap

₹9,963.92

0.03 (▲3.45%)

BSE 200

₹11,744.36

0.05 (▲5.31%)

BSE 500

₹37,369.13

0.04 (▲14.3%)

S&P BSE 100 ESG

₹433.46

0.04 (▲0.16%)

BSE 100

₹27,134.19

0.03 (▲7.94%)

Nifty LargeMidcap 250

₹16,824.70

0.06 (▲10.4%)

SENSEX

₹84,562.78

0.1 (▲84.11%)

NIFTY 100

₹26,528.00

0.08 (▲22.4%)

S&P BSE 250 LargeMidCap

₹11,137.09

0.02 (▲1.81%)

BSE Healthcare

₹44,652.86

0.22 (▲98.4%)

BSE MFG

₹1,093.39

-0.02 (▲-0.19%)

S&P BSE 100 LargeCap TMC

₹9,559.72

0.04 (▲3.69%)

Nifty100 Eq Weig

₹34,003.15

0.06 (▲19.5%)

Insights on Sun Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 13.57K Cr → 14.94K Cr (in ₹), with an average increase of 4.7% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, SUNPHARMA stock has moved up by 3.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 2.14K Cr → 3.11K Cr (in ₹), with an average increase of 16.3% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 23.4% return, outperforming this stock by 22.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.5% return, outperforming this stock by 58.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 54.48% of holdings in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 8.77% to 8.73% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 12.63% to 12.41% in Sep 2025 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 17.26% to 16.55% in Sep 2025 quarter

Sun Pharma Stock Futures & Options Contracts

View the latest movement in Sun Pharma Futures & Options, including strike prices, expiry dates, and percentage changes.

Sun Pharma Options

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 25 Nov ₹1760 Call
November 25, 2025
₹1760
₹19
3.45
22.19%
SUNPHARMA 25 Nov ₹1740 Call
November 25, 2025
₹1740
₹30
5.55
22.7%
SUNPHARMA 25 Nov ₹1800 Call
November 25, 2025
₹1800
₹6.75
1.05
18.42%
SUNPHARMA 25 Nov ₹1780 Call
November 25, 2025
₹1780
₹11.3
2.1
22.83%

Sun Pharma Futures

Name
Expiry
Strike Price
LTP
Absolute Change
Change
SUNPHARMA 25 Nov Fut
November 25, 2025
-
₹1759.3
16.04
0.92%
SUNPHARMA 30 Dec Fut
December 30, 2025
-
₹1770.9
15.8
0.9%
SUNPHARMA 27 Jan Fut
January 27, 2026
-
₹1782.9
16.08
0.91%

About Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd., incorporated in 1983, is a global specialty generic pharmaceuticals company with a presence in over 150 countries. The company is headquartered in Mumbai, India, and has operations in three primary lines of business: branded formulations, specialty generics, and active pharmaceutical ingredients (API).

Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.

Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.

Revenue: ₹14,405.22Cr as on September 2025 (Q2 FY26)
Net Profit: ₹3,137.09Cr as on September 2025 (Q2 FY26)
Listing date: 08 Feb, 1995
Revital Share Price
Volini Share Price
Abzorb Share Price
Pepfiz Share Price
OrganisationSun Pharmaceutical Industries Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs

What is Sun Pharma share price today?

Sun Pharma share price today stands at ₹1757.1 as on at the close of the market. Sun Pharma share today touched a day high of ₹1760.1 and a low of ₹1734.7.

What is the 52 week high and 52 week low range for Sun Pharma share?

Sun Pharma touched a 52 week high of ₹1910 and a 52 week low of ₹1548. Sun Pharma share price today i.e. is closed at ₹1757.1, which is -8.01% down from its 52 week high and 13.51% up from its 52 week low.

What is Sun Pharma's market capitalisation today?

Sun Pharma market capitalisation is ₹4,21,587.15 Cr as on .

How to buy Sun Pharma shares?

To buy Sun Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharma trading volume today?

Sun Pharma trading volume is 16.67L as on . This means that 16.67L shares of Sun Pharma were bought and sold on the stock market during today's trading session.